Dianthus Therapeutics
DNTH
DNTH
98 hedge funds and large institutions have $685M invested in Dianthus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.29% less ownership
Funds ownership: 118.67% → 117.38% (-1.3%)
10% less capital invested
Capital invested by funds: $766M → $685M (-$80.2M)
53% less call options, than puts
Call options by funds: $813K | Put options by funds: $1.73M
Holders
98
Holding in Top 10
6
Calls
$813K
Puts
$1.73M
Top Buyers
| 1 | +$42.8M | |
| 2 | +$23.5M | |
| 3 | +$18.1M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$11.3M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.51M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$15.1M | |
| 3 | -$14.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.06M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.01M |